Falcarindiol, an orally active polyacetylenic oxylipin, activatesPPARγand increases the expression of thecholesteroltransporter ABCA1 in cells. Falcarindiol inducesapoptosisandautophagy. Falcarindiol has anti-inflammatory, antifungal, anticancer and antidiabetic properties^[1][2].

Falcarindiol (3, 6, 12, 24 μM; for 24 hours) significantly decreases cell viability of MDA-MB-231 and MDA-MB-468 cells. Cell viability of MCF-10A cells is unchanged until the dose of Falcarindiol reaches to 24 uM. Falcarindiol preferentially induces cell death in breast cancer cells^[1].
Falcarindiol (6 uM; for 2 hours) induces autophagy and causes significant level of LC3-I converted to LC3-II in MDA-MB-231, MDA-MB-468 and SKBR3 cells^[1].
Falcarindiol (6 uM; for 2, 4, 8, 24 hours) increases the level of GRP78 in MDA-MB-231 cells in dose- and time-dependent manner^[1].
Falcarindiol (1-20 μM) has no effect on hMSCs and HT-29 cell viability. Falcarindiol with only concentrations above 50 μM exhibits a toxic effect on the cells^[2].
Falcarindiol (5 μM; 10 min, 1 h and 24 h) causes a significant upregulation on PPARγ2 expression at 24 h^[2].

Falcarindiol (7 μg/g; diet) increases ABCA1 expression in neoplastic tissue in five weeks old male rats^[2].

260.37

Oil

C₁₇H₂₄O₂

55297-87-5

法卡林二醇；镰叶芹二醇；发卡二醇

• Others

• Plants
• Umbelliferae
• Peucedanum praeruptorumDunn

Room temperature in continental US; may vary elsewhere.

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

DMSO : ≥ 33.33 mg/mL(128.01 mM)

*"≥" means soluble, but saturation unknown.

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture and light)。-80℃ 储存时，请在 6 个月内使用，-20℃ 储存时，请在 1 个月内使用。

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液，再依次添加助溶剂：

——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用； 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

• 1.

  请依序添加每种溶剂： 10% DMSO    40%PEG300   5%Tween-80   45% saline

  Solubility: 1.11 mg/mL (4.26 mM); Suspended solution; Need ultrasonic

  此方案可获得 1.11 mg/mL (4.26 mM) 的均匀悬浊液，悬浊液可用于口服和腹腔注射。

  以 1 mL 工作液为例，取 100 μL 11.1 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

  将 0.9 g 氯化钠，完全溶解于 100 mL ddH2O 中，得到澄清透明的生理盐水溶液